Liver Formula
Generic Name: liver formula
Brand Names:
Liver Formula 2102
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of minor abdominal pain or swelling, fatigue, irritability, constipation, loss of appetite, or low energy level.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS Severe or persistent symptoms may be serious. Consult a doctor promptly. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Liver Formula used for?▼
INDICATIONS For the temporary relief of minor abdominal pain or swelling, fatigue, irritability, constipation, loss of appetite, or low energy level.*
Can I take Liver Formula during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Liver Formula?▼
WARNINGS Severe or persistent symptoms may be serious. Consult a doctor promptly. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Elamipretide Acetate
elamipretide acetate
Dosage form: POWDER. Active ingredients: ELAMIPRETIDE (1 g/g). Category: BULK INGREDIENT.
Tarlatamab-dlle
tarlatamab-dlle
11 DESCRIPTION Tarlatamab-dlle is a bispecific DLL3-directed CD3 T-cell engager that binds to DLL3 expressed on the surface of cells, including tumor cells, and CD3 expressed on the surface of T cells. Tarlatamab-dlle is produced using recombinant DNA technology in Chinese hamster ovary cells. It consists of 982 amino acids and has a molecular weight of approximately 105 kilodaltons.
Norelgestromin And Ethinly Estradiol
norelgestromin and ethinly estradiol
Estrogen [EPC]
11 DESCRIPTION Norelgestromin and ethinyl estradiol transdermal system has a contact surface area of 12.5 cm 2 . It contains 3.15 mg norelgestromin, USP (NGMN) and 0.289 mg ethinyl estradiol, USP (EE), and its delivery rate is approximately 150 mcg of NGMN, USP and 35 mcg of EE, USP per day.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.